BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 23356858)

  • 1. Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers.
    Harris AHS; Ellerbe L; Reeder RN; Bowe T; Gordon AJ; Hagedorn H; Oliva E; Lembke A; Kivlahan D; Trafton JA
    Psychol Serv; 2013 Nov; 10(4):410-419. PubMed ID: 23356858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of alcohol use disorders by the Veterans Health Administration: patterns of receipt and persistence.
    Harris AH; Oliva E; Bowe T; Humphreys KN; Kivlahan DR; Trafton JA
    Psychiatr Serv; 2012 Jul; 63(7):679-85. PubMed ID: 22549276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration.
    Harris AH; Kivlahan DR; Bowe T; Humphreys KN
    Psychiatr Serv; 2010 Apr; 61(4):392-8. PubMed ID: 20360279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' opinions about medications to treat alcoholism.
    Mark TL; Kranzler HR; Song X; Bransberger P; Poole VH; Crosse S
    Addiction; 2003 May; 98(5):617-26. PubMed ID: 12751979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions.
    Williams EC; Matson TE; Harris AHS
    Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol dependence treatments: comprehensive healthcare costs, utilization outcomes, and pharmacotherapy persistence.
    Baser O; Chalk M; Rawson R; Gastfriend DR
    Am J Manag Care; 2011 Jun; 17 Suppl 8():S222-34. PubMed ID: 21761948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Group management of pharmacotherapy for alcohol dependence: feasibility and impact on adoption.
    Robinson S; Bowe T; Harris AH
    J Subst Abuse Treat; 2013; 45(5):475-7. PubMed ID: 23932227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to and facilitators of pharmacotherapy for alcohol use disorder in VA residential treatment programs.
    Finlay AK; Ellerbe LS; Wong JJ; Timko C; Rubinsky AD; Gupta S; Bowe TR; Burden JL; Harris AHS
    J Subst Abuse Treat; 2017 Jun; 77():38-43. PubMed ID: 28476269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pharmacologic treatment of the alcohol dependence].
    Castro LA; Baltieri DA
    Braz J Psychiatry; 2004 May; 26 Suppl 1():S43-6. PubMed ID: 15729444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New pharmacotherapies for alcohol dependence.
    Graham R; Wodak AD; Whelan G
    Med J Aust; 2002 Jul; 177(2):103-7. PubMed ID: 12098353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of alcohol dependence: a review of the evidence.
    Garbutt JC; West SL; Carey TS; Lohr KN; Crews FT
    JAMA; 1999 Apr; 281(14):1318-25. PubMed ID: 10208148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for alcohol dependence: status of current treatments.
    Franck J; Jayaram-Lindström N
    Curr Opin Neurobiol; 2013 Aug; 23(4):692-9. PubMed ID: 23810221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the adoption of medications for alcohol dependence.
    Ducharme LJ; Knudsen HK; Roman PM
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S13-9. PubMed ID: 17114950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic and geographic disparities in access to pharmacotherapy for alcohol dependence.
    Morley KC; Logge W; Pearson SA; Baillie A; Haber PS
    J Subst Abuse Treat; 2017 Mar; 74():23-25. PubMed ID: 28132696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments in the pharmacotherapy of alcohol dependence.
    Schuckit MA
    J Consult Clin Psychol; 1996 Aug; 64(4):669-76. PubMed ID: 8803356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.
    Starosta AN; Leeman RF; Volpicelli JR
    J Psychiatr Pract; 2006 Mar; 12(2):80-9. PubMed ID: 16728904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.
    Thompson A; Ashcroft DM; Owens L; van Staa TP; Pirmohamed M
    PLoS One; 2017; 12(3):e0173272. PubMed ID: 28319159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.